Objective-The goal of this study was to determine the in vivo functions of the synaptic proteins neurexins and neuroligins in embryonic vascular system development using zebrafish as animal model. Methods and Results-In the present study, we show that the knockdown of the α-form of neurexin 1a induces balance defects and reduced locomotory activity, whereas β-neurexin 1a and neuroligin 1 morphants present defects in sprouting angiogenesis and vascular remodeling, in particular in the caudal plexus and subintestinal vessels. Coinjection of low doses of morpholinos for β-neurexin 1a and neuroligin 1 together or in combination with morpholinos targeting the heparinbinding isoforms of vascular endothelial growth factor A (encoded by the VEGFAb gene) recapitulates the observed abnormalities, suggesting synergistic activity of these molecules. Similar coinjection experiments with morpholinos, targeting the enzyme heparan sulfate 6-O-sulfotransferase 2, confirm the presence of a functional correlation between extracellular matrix maturation and β-neurexin 1a or neuroligin 1. Conclusion-Our data represent the first in vivo evidence of the role of neurexin and neuroligin in embryonic blood vessel formation and provide insights into their mechanism of action. (Arterioscler Thromb Vasc Biol. 2012;32:1563-1572)
Integrative Physiology/Experimental Medicine N eurexins (NRXNs) are a family of cell adhesion molecules involved in the modulation of synaptic activity. 1 In mammals, there are 3 different NRXN genes, each presenting 2 alternative promoters which drive the synthesis of 2 major isoforms per gene (a long α-NRXN, and a short C-terminal β-NRXN) 2 whereas a further degree of heterogeneity is obtained through extensive alternative splicing events. 3 Neuroligins (NLGNs) are the best-characterized interactors of NRXNs. 1 In mammals, there are at least 4 different NLGN genes (5 in Homo sapiens), which encode for postsynaptic transmembrane molecules. In the last years, several reports have presented about the involvement of different mutations of NRXNs and NLGNs in autism and other human cognitive diseases. 4 In mice, knocking-out NLGNs 1-3 or the 3 α-forms of NRXN reveal a role of these molecules in the fine modulation of synaptic activity. 5, 6 Notably, experimental data about the in vivo function of β-NRXNs in knockout mice are still missing.
See accompanying article on page 1546
Vascular endothelial growth factor A (VEGFA) is the most studied and the best characterized member of the VEGF family and is a key regulator of angiogenesis via its ability to affect endothelial cells proliferation, migration, and differentiation. 7 In mammals, VEGFA is alternatively spliced giving rise to different isoforms. In humans, the most common are VEGFA121, VEGFA165, and VEGFA189, which differ in their affinity for heparan sulphate and coreceptor binding. 8 Indeed, VEGFA121 is freely diffusible in the extracellular space, whereas VEGF165 and VEGF189 exhibit moderate or high affinity for heparan sulfate proteoglycans (HSPGs), transmembrane or secreted proteins with covalently linked heparin sulfate chains able to modulate the activity of secreted signaling molecules. 9, 10 In particular, heparan sulfates can modulate the biological activity of the different isoforms of VEGFA in vivo. As demonstrated by the analysis of VEGFA 120/120 knock-in mice, the lack of heparin-dependent VEGF isoforms reduces vascular branching and increases vessels caliber. [11] [12] [13] In zebrafish, the VEGFA gene is duplicated and the 2 genes are named VEGFAa and VEGFAb. 14 VEGFAa can produce 2 different isoforms (VEGFAa121 and 165), whereas VEGFAb encodes the homologues of human VEGFA165 and VEGFA189 (VEGFAb171 and 210, respectively), 14 which are both extracellular matrix (ECM)-dependent.
The Synaptic Proteins β-Neurexin and Neuroligin Synergize With Extracellular Matrix-Binding Vascular Endothelial Growth Factor A During Zebrafish Vascular Development
The molecular cues shared between the nervous and vascular systems are mainly involved in axon/vessel guidance, boundary formation, and cell fate specification. 15 Nevertheless, we recently demonstrated that NRXNs and NLGNs are expressed in the vascular system and contribute to its function. 16 In parallel, we identified the members of zebrafish (Danio rerio) NRXN and NLGN gene families. 17, 18 To deepen the functional characterization of these 2 gene families in vascular development, we took advantage of the zebrafish model system to perform an in vivo study. Given the lack of in vivo functional data for β-NRXNs and starting from our previous findings, 16 we focused our analyses on the β-nrxn1a and nlgn1 genes. Expression analyses indicate that both genes are expressed in endothelial and mesenchymal cells of the trunk/tail region of zebrafish embryos. The knockdown with morpholinos (MOs) for β-nrxn1a or nlgn1 but not for α-nrxn1a specifically reduces sprouting angiogenesis of the caudal plexus (CP) and, at later stages of development, it impairs the formation/stability of blood vessels also in other vascular districts. Furthermore, we show a genetic interaction of β-nrxn1a and nlgn1 with both ECM-dependent VEGFA isoforms and the matrix modifying heparan sulfate 6-O-sulphotransferase 2 (HS6ST2). Our data represent the first in vivo report of the function of these genes in the vascular system, giving new insights into their possible mechanism of action.
Methods

Zebrafish Lines and Maintenance
Zebrafish lines and embryos were raised and maintained according to established conditions. 18, 19 The following lines were used: Tg(gata1:dsRed) 20 and Tg(flk1:EGFP). 21 The double transgenic line Tg(gata1:dsRed) sd2 ;(kdrl:EGFP) s843 was a generous gift from Dr Massimo Santoro (Laboratory of Cardiovascular Biology, Molecular Biotechnology Center, Torino, Italy). Wild-type fish used in this study include AB and TL lines.
Morpholinos
Antisense morpholinos were purchased from Gene Tools (LLC, Philomath, OR). Different doses of MOs were diluted in Danieau buffer or water and then injected into 1-to 2-cell stage embryos. The phenotypic effects of each MO was tested by dose escalation. See Table I in the online-only Data Supplement for a complete list of MOs and doses.
Reverse Transcriptase-Polymerase Chain Reaction
Total RNA samples preparation, reverse transcription, and PCR reactions were performed, as previously described. 17 Products were then separated on agarose gels and visualized by ethidium bromide staining.
Sorting of Endothelial EGFP + Cells and Quantitative PCR
Endothelial cells were isolated from Tg(kdrl:EGFP) la116 embryos at 30 to 35 hours postfertilization (hpf) by fluorescence-activated cell sorting, as described previously. 22 Total RNA from EGFP + and EGFP − populations was isolated in Trizol (Invitrogen) according to manufacturer's instructions. cDNA strands were synthesized using SuperScript III following manufacturer's instructions (Invitrogen). The products were amplified in real-time PCR reactions with StepOne Plus Real-Time PCR System (Applied Biosystems) using PCR master mix PowerSYBR Green (Applied Biosystems). The results of a representative experiment are shown in Figure IF in the online-only Data Supplement. See Table II in the online-only Data Supplement for a list of primers used in quantitative PCR.
In Situ Hybridization
Whole mount in situ hybridizations were performed, as elsewhere described. 23 Specific probes for nlgn1, cdh5, vsg1, flk1, tie2, and flt4 were synthesized and used, as previously described. 18, 23 All the probes were purified using Spin Post-Reaction Clean-Up Columns ( Sigma-Aldrich, St Louis, MO) before use. We used 2 different probes for the nrxn1a gene: a probe specific for both αand β-forms and a second probe specific only for β-forms. For α/β nrxn1a probe, primers were designed to cover the 3′-end of the coding sequence and part of the 3′untranslated region of the nrxn1a gene; for β NRXN1a probe, primers cover the 5′untranslated region and the β-specific exon.
Imaging
Images were taken with a Leica MZFLIII epifluorescence stereomicroscope equipped with a DFC 480 R2 digital camera or with a Leica DM6000 B microscope equipped with a DFC 360 FX digital camera and LAS Leica imaging software (Leica, Wetzlar, Germany). For confocal microscopy, embryos were mounted in 0.5% to 1% low melting agarose and the medium was supplemented with 0.1% Tricaine. Imaging was performed on a Leica TCS SP2 confocal microscope (Leica Microsystems) using a 10× or 20× objective. In timelapse confocal analysis, time points were recorded every 17 to 20 minutes. Images were processed using Adobe Photoshop software (Adobe, San Jose, CA) whereas movies were processed using Sorenson Squeeze 5 (Sorenson Media Inc) or edited using VEGAS 9.0 (Sony Creative Software Inc).
Alkaline Phosphatase Staining
Alkaline phosphatase staining was performed, as previously described. 23
Semithin Plastic Sections
Embryos for histological analysis were fixed and embedded, as previously described. 23
Statistical Analysis
Unless otherwise indicated, the percentage of affected embryos observed in wild-type or ST-CTRL MO-injected embryos have been subtracted from the percentages observed in morphants. Results are expressed as the mean±standard deviation or standard error of the mean. Differences were determined by repeated-measures ANOVA with Dunnett post hoc analysis using GraphPad PRISM version 5.0 (GraphPad, San Diego, CA). Embryos coinjected with the α-NRXN1a MO have been used as reference groups. A P<0.05 indicates a statistically significant effect.
Results
β-nrxn1a and nlgn1 Are Expressed in Endothelial Cells and Modulate Vascular Development
The spatiotemporal analysis of α/β-nrxn1a by whole mount in situ hybridizations showed that around 33 hpf they are expressed in different regions of the nervous system ( Figure I in the online-only Data Supplement). Moreover, we also observed a faint signal in the ventral region of the embryos below the notochord (black arrows in Figure IA in the online-only Data Supplement). Further analyses, using ISH probes specific for β-nrxn1a and nlgn1 followed by histological sectioning of hybridized embryos, indicated that CP and the surrounding mesenchymal cells express both transcripts ( Figure IB To determine the role of nrxn1a and nlgn1 in zebrafish embryo development, we targeted both the major forms (α and β) of nrxn1a and the nlgn1 gene using specific MOs (see Table I in the online-only Data Supplement). The injection of a specific translation-blocking MO for α-nrxn1a (α-NRXN1a MO) produced no evident vascular defects (Figures IJ, IV, VB, VI, and IX in the online-only Data Supplement). However, at 3 days postfertilization (dpf) α-NRXN1a MO-injected embryos (morphants) displayed a severe impairment of their locomotory activity without visible defects in the formation or maintenance of trunk muscles (data not shown). In particular, they usually failed to maintain body balance and presented a very low performance in touch response tests (see Videos I and II in the online-only Data Supplement). Different reports indicate that MO injection can induce off-target effects through p53 activation, 24, 25 in particular neural toxicity. However, the coinjection of α-NRXN1a MO with p53 MO did not rescue the phenotype in touch-response assays, indicating that locomotory defects are not attributable to a generic p53 activation ( Figure II in the online-only Data Supplement). The molecular bases of the locomotory defects caused by α-NRXN1a MO were not analyzed further. Moreover, given the lack of significant vascular phenotypes, α-NRXN1a MO was used as internal control in the following experiments of β-nrxn1a and nlgn1 knockdown.
To knockdown β-nrxn1a gene, we used 2 different MOs: a translation-blocking (β-NRXN1a MO1) and a splice-blocking MO (β-NRXN1a MO2). The effectiveness of the splice-blocking MO was confirmed by reverse transcriptase-polymerase chain reaction ( Figure 1 and Figure  IK in the online-only Data Supplement). The injection of either 1 of these 2 different MOs targeting β-nrxn1a transcripts into Tg(flk1:EGFP) embryos showed that up to 24 hpf the vascular system develops normally (data not shown), but by 26 hpf a specific CP alteration is evident ( Figure 2A ). In zebrafish, caudal vein morphogenesis requires 2 steps: first, around 26 hpf, the caudal part of the axial vein undergoes sprouting angiogenesis and becomes a plexus of vessels (Figures 2A  and 3 ) that continues to grow until 48 hpf; then its maturation through progressive remodeling will produce a well-structured and hierarchic vascular network ( Figure 2B ). 26, 27 The confocal analysis performed on Tg(flk1:EGFP)-injected embryos between 26 and 32 hpf showed that CP reduction in β-nrxn1a morphants is attributable to a limited ventral sprouting and branching of the caudal vein (Figure 2A ; Figure IJ and Videos III and IV in the online-only Data Supplement). Notably, other vascular structures such as the intersegmental vessels (ISVs) form normally. At 32 hpf ISVs still appear largely unaffected, whereas the CP remains drastically reduced therefore excluding a possible developmental delay (see white brackets in Figure 2A and Figure IJ in the online-only Data Supplement). The injection of a translation-blocking MO targeting nlgn1 transcripts produced similar vascular phenotypes (data not shown). Recently, Mouillesseaux and Chen 28 showed that LA1908 mutants present CP defects attributable to the lack of utp15 activity. This deficiency induces a p53-mediated antiangiogenic effect on CP development. Moreover, they showed that blocking p53 activation in LA1908 mutants by p53 MO injection rescued the vascular defects in the CP region. To further prove the specificity of our observed vascular phenotypes, we coinjected p53 MO with high doses of β-NRXN1a or NLGN1 MOs. The coinjection experiments indicate that p53 activation is not involved in vascular phenotypes The confocal analyses of Tg(gata1:dsRed) sd2 ;(kdrl:EGFP) s843 embryos at around 54 hpf ( Figure 2B) show that CP of control embryos consists of a major venous vessel (CV in Figure  2B ) located in its ventral-most part. However, a plexiform portion is still present in the dorsal-most part, beneath the dorsal aorta (DA in Figure 2B ). Notably, from this stage on circulation is mostly restricted to the single major venous vessel and only few blood cells flow into the plexiform portion ( Figure 2B ). At the same stage, β-nrxn1a and nlgn1 morphants presented an anomalous blood circulation in their tail region ( Figure 2B and Figure IXA in the online-only Data Supplement). Indeed, blood circulation is mainly restricted to the dorsal-most part of the plexiform region and some tracts of the ventral-most vessels present a partial or complete lack of blood circulation (arrows in Figure 2B ), suggesting an altered organization of the CP. To verify this hypothesis, we analyzed vessels morphology of β-NRXN1a MOs and NLGN1 MO-injected embryos by histological sectioning ( Figure VA in the online-only Data Supplement). Semithin plastic sections showed that the observed blood flow variation in the CP region of β-nrxn1a and nlgn1 morphants is attributable to a specific dilation of the dorsal-most vessels at the expense of the ventral ones (black arrows and arrowheads, respectively in Figure VA in the online-only Data Supplement). Altogether, the confocal and histological analyses suggest that this altered organization of CP is attributable to vascular defects during its formation and subsequent remodeling.
Because of progressive remodeling of the CP, at later stages of development the vascular defects in CP appear less evident, but additional vascular defects arise. Around 3 dpf, some parts of the dorsal longitudinal anastomotic vessels and some ISVs of β-nrxn1a morphants lose blood circulation and start to regress, detaching from adjacent endothelial cells (see insets in Figure VI and Videos V and VI in the online-only Data Supplement). Finally, we observed that β-nrxn1a and nlgn1 morphants showed a range of defects in the subintestinal veins (SIVs) as revealed by endogenous alkaline phosphatase staining at 3 dpf ( Figure VB in the online-only Data Supplement). The defective SIVs presented a severe reduction with sporadic elongated spikes extending toward the yolk. Notably, SIVs of α-nrxn1a morphants appear substantially unaffected ( Figure  VB in the online-only Data Supplement). Overall, these data indicate that nlgn1 and only the β-forms of nrxn1a are involved in embryonic vascular development and in particular in CP and SIVs formation.
Synergistic Interaction of β-nrxn1a and nlgn1 in CP Formation and Their Correlation With VEGFA
Although zebrafish represents 1 of the most recent animal models used in vascular biology, it provides a very useful tool to study the vascular system. 29, 30 Different studies have highlighted a strong similarity between zebrafish and other animal models in basic molecular mechanisms of vascular development 29 and in particular in sprouting angiogenesis. 31, 32 Nevertheless, the majority of these studies focused on ISVs formation and few of them drew attention to the mechanisms regulating CP formation. 26, 28, [33] [34] [35] [36] [37] [38] [39] [40] [41] Therefore, we focused our attention on this structure. Using a previously published MO for VEGFAb, 14 we observed vascular defects in SIVs ( Figure VIIA in the online-only Data Supplement) as observed by the authors. Interestingly, we also observed that VEGFAb morphants present severe defects in CP formation ( Figure VIIB in the online-only Data Supplement). As described above for β-nrxn1a and nlgn1 morphants, CP defects are associated with a reduced expression of several vascular markers in this structure ( Figure VIIC in the online-only Data Supplement) and a dilation of the dorsal-most vessels of the plexus ( Figure VIII in the online-only Data Supplement). Although a previous report indicated that VEGFAa MO-injected embryos presented a lack of CP formation, 40 at the selected dose (0.6 pmol/ embryo) we observed only mild defects within the CP in a low percentage of embryos (Figures IXB and VIII in the online-only Data Supplement for a histological analysis of VEGFAa morphants). Next, we reasoned that VEGFAs, and in particular VEGFAb, might be directly or indirectly involved in the phenotypes observed in β-nrxn1a and nlgn1 morphants. To investigate the effect of the concurrent loss of endogenous VEGFAs and β-nrxn1a or nlgn1 on CP formation, we coinjected low doses of specific MOs in Tg(gata1:dsRed) embryos ( Figure 4 ). As previously shown, the blood flow variation observed in β-nrxn1a and nlgn1 morphants embryos is indicative of the presence of specific vascular defects in CP. Using doses at which each MO alone produced defects with negligible penetrance ( Figure IXC and IXD in the online-only Data Supplement), we observed significant defects in the CP in embryos coinjected with β-NRXN1a MO1 and NLGN1 MO (≈53%, n=250) ( Figure  4B ), further indicating that these molecules are both involved in plexus formation. Moreover, we found a more than additive effect by coinjecting β-NRXN1a MO1 or NLGN1 MO with both VEGFAa and VEGFAb MOs, albeit with a different degree of penetrance (Figure 4) . Notably, a low dose of α-NRXN1a MO alone or in coinjection with β-NRXN1a MO1, NLGN1 MO, or VEGFAb MO produced milder vascular defects and minimal additive effects ( Figure 4B and Figure IXC and IXD in the online-only Data Supplement).
Taken together, these data highlight a distinct role between VEGFAa and VEGFAb isoforms in vascular development. In particular, our data suggest a pivotal function of VEGFAb in CP formation, whereas VEGFAa isoforms are more involved in ISVs and only partially in CP formation, as previously indicated by other studies. 40, 42 Moreover, these results indicate a synergy of action of β-NRXN1a and NLGN1 MOs together or in coinjection with VEGFAs MOs, suggesting an interplay between all these molecules in the vascular system.
β-nrxn1a and nlgn1 Are Involved in CP Formation in Synergy With the Heparin-Binding Isoforms of VEGFA and the Heparan Sulfate 6-O-Sulphotransferase 2 Enzyme
It is interesting to note that the coinjection of VEGFAa MO with β-NRXN1a or NLGN1 MOs presents a lower degree of effectiveness (≈35%, n=87 and ≈33%, n=134, respectively) than the coinjection of VEGFAb MO with β-NRXN1a MO1 or NLGN1 MO (≈59%, n=162 and ≈55%, n=178, respectively) ( Figure 4B ). We supposed that a possible explanation might reside in the differential affinity for HSPGs of the different isoforms produced by VEGFAa and VEGFAb genes. A perturbation of HSPGs can result in a variation of morphogen gradients in ECM or alternatively it can interfere with stabilization of signaling complexes. 43 To test this hypothesis, we perturbed the overall HSPGs maturation by injecting a previously published MO targeting HS6ST2 34 . Sulphotransferases contribute to the heterogeneity of heparan sulphates and ECM maturation, which is essential for the modulation of ligand-receptor binding. 7 In particular, the knockdown of zebrafish HS6ST2 induced a reduction of vascular branching in the CP compromising a correct VEGFA gradient formation. 34 Moreover, at 5 dpf hyaloid vessels of HS6ST2 morphants 44 fail to remodel, producing vessels very similar to the vascular phenotype observed in the retina of VEGFA 120/120 knock-in mice 13 Figure 5A and Figure IXD in the online-only Data Supplement), it prevented a correct formation of CP in coinjection with low doses of β-NRXN1a MO1 (≈58%, n=102), NLGN1 MO (≈48%, n=231), VEGFAb MO, or VEGFAa MO (≈55%, n=123 and ≈36%, n=107, respectively) ( Figure 5) .
Notably, the percentage of affected embryos in coinjection with VEGFAa MO was lower and they presented mild vascular defects ( Figure 5) . These experiments suggest that the establishment of a VEGFA gradient is necessary for a correct CP formation during embryo development. Moreover, they indicate that the effects of the injection of β-NRXN1a and NLGN1 MOs can be enhanced by defects in ECM maturation and the consequent alteration of morphogen gradients, in particular that of VEGFAb.
SIVs Development Is Also Affected by the β-nrxn1a/ nlgn1/VEGFAb/HS6ST2 Axis
As previously described, the knockdown of β-nrxn1a, nlgn1, or VEGFAb induced defects in SIVs formation (Figures VB and VIIA in the online-only Data Supplement). To further sustain these data, we tested the effects of the different combinations of MOs on SIVs formation using endogenous alkaline phosphatase staining at 3 dpf ( Figure 6 ). The single injection at low doses of each different MO (data not shown) or their coinjection with α-NRXN1a MO did not produce significant vascular defects at SIVs (see Figure 6A and 6B). The injection of a high dose of HS6ST2 MO impaired a correct formation of SIVs ( Figure 6A) and, as previously observed for the CP, the coinjection of VEGFAb MO with β-NRXN1a MO1 (≈48%, n=110) or NLGN1 MO (≈51%, n=132) proved to be more effective in affecting SIVs growth than the coinjection with VEGFAa MO ( Figure 6B) . Notably, the effect of the coinjections with VEGFAb are comparable to those observed coinjecting β-NRXN1a MO1 and NLGN1 MO (≈50%, n=260). Moreover, HS6ST2 MO impaired SIVs morphogenesis when associated with β-NRXN1a MO1 (≈38%, n=95), NLGN1 MO (45%, n=144) or VEGFAb MO (33%, n=89) ( Figure 6A and 6C) . Finally, VEGFAa MO failed to impair SIV morphogenesis in coinjection with HS6ST2 MO (Figure 6A and 6C) . Taken together, these data indicate that VEGFAb genetically interacts with β-NRXN1a and NLGN1 also during SIV morphogenesis and highlight the importance of the ECM maturation for a correct formation of the SIVs.
Discussion
In this study, we took advantage of the zebrafish animal model to deepen the knowledge on the role of the synaptic proteins NRXNs and NLGNs in vascular development. Through whole mount in situ hybridizations and real-time reverse transcriptase-polymerase chain reaction analyses, we observed that during embryo development β-nrxn1a and nlgn1 are expressed in endothelial cells of CP and surrounding mesenchymal cells, whereas α-forms of nrxn1a are mainly expressed in different regions of brain and spinal cord. Consistent with our expression data, the knockdown of α-forms of nrxn1a resulted in a reduced locomotory activity of the injected embryos without evident vascular defects. Notably, previous independent studies have indicated that in Drosophila melanogaster the single α-NRXN protein is important for neurotransmission at neuromuscular junctions and consequently for larvae locomotion. 45, 46 In contrast, from 26 hpf the knockdown of β-nrxn1a and nlgn1 specifically induced vascular defects in CP region. The observed defects consist in a reduction of vessel sprouting and a concurrent decrease in branching which affect plexus morphology also at later stages. These results suggest a role of β-nrxn1a and nlgn1 in sprouting angiogenesis and vascular plexus remodeling and confirm our previous data obtained in the chicken chorioallantoic membrane model using an anti-β-NRXN blocking antibody. 16 Furthermore, our recent experiments show that downregulation of neuroligin 1 by siRNA in human endothelial cells causes a strong decrease of their tubulogenetic/ morphogenetic capacity in the in vitro matrigel angiogenesis assay (A.V. Samarelli, manuscript in preparation, 2012). The alteration of a correct plexus formation in β-nrxn1a and nlgn1 morphants has consequences in the later phases of embryo development. At 54 hpf, the dorsal-most vessels of CP present a specific dilation at the expense of the ventral part, which in some tracts presents a reduced or absent blood flow attributable to the reduced lumen of the vessels as assessed by confocal and histological analyses. In β-nrxn1a morphants, although ISVs grow normally indicating no vascular patterning or guidance defects, around 72 hpf some of them present a reduced circulation and apparently begin to lose their cellular associations with neighboring endothelial cells and then regress. The blood vessels regression in CP, dorsal longitudinal anastomotic vessels, and ISVs can be explained by a reduction/lack of blood flow and of the resultant shear stress on endothelial cells. Blood flow-induced shear stress can indeed regulate different endothelial cell functions such as migration, proliferation, remodeling, and apoptosis. 47 As previously observed by Isogai et al, 48 in zebrafish the emergence of secondary sprouts from the cardinal vein is genetically programmed. These sprouts require blood flow to sustain and finally fix the new venous identity of ISVs and in the absence of blood flow the new connection usually undergoes regression. 48 More recently, Choi et al 26 showed that circulation is necessary for the maintenance of the CP structure only in the late phases of its development. As demonstrated by different studies in other animal models, 49 blood flow plays also a pivotal role in vessels lumen regulation. Finally, given that in β-nrxn1a morphants only a subset of ISVs and dorsal longitudinal anastomotic vessels undergo vascular regression, another possibility is that arterial versus venous fate decision might be involved. Future analyses will be finalized to characterize the nature of these defective vessels and to investigate the molecular mechanisms involved in this specific lack of blood circulation.
Using a loss-of-function approach, we show that β-nrxn1a and nlgn1 synergistically cooperate during CP and SIVs formation. This event logically follows 2 facts: the physical association of β-NRXN and NLGN in blood vessels 16 and their innate partnership at the synapse. 50 Moreover, we show that in both vascular structures the action of both β-nrxn1a and nlgn1 is genetically linked to VEGFAs. As shown by coinjection experiments, the role of β-nrxn1a and nlgn1 is associated to the isoforms more dependent on the ECM such as the VEGFAa165 and in particular to both isoforms produced by the VEGFAb gene. 14 Previous studies indicated that VEGFAa, and in particular the VEGFAa121 isoform, is mainly involved in ISVs formation, 40, 42 whereas the VEGFAa165 isoform has been more implicated in CP 34, 40, 51 and SIVs formation. 40 Our data and a previous independent study 14 indicate that the knockdown of VEGFAb induced vascular defects at the SIVs. We expanded these last observations by pointing out that VEGFAb is also strongly involved in CP formation. Both VEGFAb isoforms interact with HSPGs creating a gradient in the ECM, and our data indicate that a correct formation of the gradient is important for VEGFAb activity and consequently for CP and SIV morphogenesis. Recently, Wiley et al 41 showed that also Bmp2 signaling is involved in CP formation; notably, BMPs-mediated processes involve their interaction with HSPGs in the ECM. As for VEGFAb isoforms, the interaction of BMPs with HSPGs restricts their diffusion creating a morphogen gradient in the extracellular environment.
In conclusion, how are NRXN and NLGN connected to VEGFA? Preliminary experiments show that β-NRXN1a and VEGFAs are correlated at the transcriptional level ( Figure X in the online-only Data Supplement) in zebrafish embryos between 24 and 30 hpf: when β-NRXN1a is downregulated, the VEGFAb (but not VEGFAa) transcripts are upregulated. Although this event needs further investigation into its meaning and mechanism, it strongly substantiates our above findings, ie, the existence of a specific link between β-NRXN1a and heparin-binding VEGFA, and the possibility that NRXNs and VEGFA act within the same cellular pathway, so that if 1 of them is downregulated, the other undergoes a compensatory rise in expression. In conclusion, our findings have 2 major implications for the field of neurovascular biology. First, they represent the first in vivo data about the role of NRXNs and NLGNs in vascular system development, further supporting our previous results in other species 16 and expanding the number of molecules important in neuronal and vascular systems functions. Second, they indicate that members of a heterogeneous and complex family of neuronal proteins with cellular functions distant from the most classic angiogenic behaviors 2 (proliferation, migration, and adhesion) are linked to a master regulator of angiogenesis such as VEGFA.
